Page last updated: 2024-10-24

caffeine and Pancreatic Insufficiency

caffeine has been researched along with Pancreatic Insufficiency in 1 studies

Research Excerpts

ExcerptRelevanceReference
"Caffeine was a marker of capsule dissolution, and tributyrin to butyrate conversion measured pancrelipase activity."1.91In vitro evaluation of the gastrointestinal delivery of acid-sensitive pancrelipase in a next generation enteric capsule using an exocrine pancreatic insufficiency disease model. ( Agisson, M; Duysburgh, C; Gonzalez, V; Govaert, M; Jannin, V; Madit, N; Marzorati, M, 2023)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Jannin, V3
Duysburgh, C3
Gonzalez, V3
Govaert, M3
Agisson, M3
Marzorati, M3
Madit, N3

Other Studies

1 other study available for caffeine and Pancreatic Insufficiency

ArticleYear
In vitro evaluation of the gastrointestinal delivery of acid-sensitive pancrelipase in a next generation enteric capsule using an exocrine pancreatic insufficiency disease model.
    International journal of pharmaceutics, 2023, Jan-05, Volume: 630

    Topics: Caffeine; Capsules; Duodenum; Exocrine Pancreatic Insufficiency; Gastrointestinal Agents; Gelatin; H

2023
In vitro evaluation of the gastrointestinal delivery of acid-sensitive pancrelipase in a next generation enteric capsule using an exocrine pancreatic insufficiency disease model.
    International journal of pharmaceutics, 2023, Jan-05, Volume: 630

    Topics: Caffeine; Capsules; Duodenum; Exocrine Pancreatic Insufficiency; Gastrointestinal Agents; Gelatin; H

2023
In vitro evaluation of the gastrointestinal delivery of acid-sensitive pancrelipase in a next generation enteric capsule using an exocrine pancreatic insufficiency disease model.
    International journal of pharmaceutics, 2023, Jan-05, Volume: 630

    Topics: Caffeine; Capsules; Duodenum; Exocrine Pancreatic Insufficiency; Gastrointestinal Agents; Gelatin; H

2023
In vitro evaluation of the gastrointestinal delivery of acid-sensitive pancrelipase in a next generation enteric capsule using an exocrine pancreatic insufficiency disease model.
    International journal of pharmaceutics, 2023, Jan-05, Volume: 630

    Topics: Caffeine; Capsules; Duodenum; Exocrine Pancreatic Insufficiency; Gastrointestinal Agents; Gelatin; H

2023